NCT06639074 2025-10-02
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
4 trialsNCT02465268 2025-01-14
ATTAC-II
University of Florida
Phase 2 Completed
NCT03848182 2024-04-18
Analyzing Childhood Recall Antigens in Patients With Pancreatic Cancer
Albert Einstein College of Medicine
Phase 2 Terminated
NCT02700841 2024-03-12
Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation
University of Nebraska
Phase 2 Terminated